CompoAtlas

Divine Essence Lavandin Abrialis

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Lavandula x intermedia

Source : Sommité en fleurs (herbe)

100 %

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 2 Goutte(s) ; maximum: 5 Goutte(s)3 Tous les jours

Uses authorised in Canada

Utilisée en aromathérapie pour aider à soulager les maux de tête. Utilisée en aromathérapie comme calmant pour apaiser l'inquiétude et le sommeil. Utilisée en aromathérapie pour aider à soulager le rhume et la toux.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Union Nature Aroma-Phyto Inc.
NPN or DIN-HM
80063435
Status
Active licence
Licence date
18 August 2015
Revision date
Not provided
Form
Liquide
Route of administration
Topique
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80063435

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Divine Essence Lavandin Abrialis”, https://compoatlas.com/en/supplements/canada/80063435-divine-essence-lavandin-abrialis, updated 18 August 2015.

Enter to analyse, Shift+Enter for a new line